首页> 外文期刊>Medicinal Plants >Paris polyphylla Smith: a medicinally important plant species is in high risk in Himalayan region
【24h】

Paris polyphylla Smith: a medicinally important plant species is in high risk in Himalayan region

机译:巴黎多叶植物史密斯:在喜马拉雅地区,药用重要的植物物种处于高风险中

获取原文
获取原文并翻译 | 示例
           

摘要

Paris polyphylla, locally called Satuwa is one of the high demand medicinal plant of the Himalayan region is facing serious threats because of its uncontrolled and unscientific exploitation from natural pockets, because of this the plant comes under the rare category of plants of IUCN. During the last few years the local peoples of the naturally growing areas of the P. polyphylla know about its economic importance due to the huge demands from across the borders, especially from China. At present theplant is extensively using in Traditional Chinese Medicine System (TCMS) and they have been using this herb as traditional medicine for the treatment of cancer. Unhealthy competition between the collectors has led to the overharvesting of P. polyphylla without the consideration of its sustainable regeneration. Seeds and rhizomes are the medium of the propagation of this plant and if the plant is collected before the maturation of seeds, the regeneration and survival of this valuable plant will be definitely in risk in near future. Therefore, this article is highlighted and suggested the immediate need of conservation of Paris polyphylla for future generation.
机译:巴黎多叶植物,当地人称其为Satuwa,是喜马拉雅地区高需求的药用植物之一,由于其对自然资源的不受控制和不科学的开采而面临着严重的威胁,因为这种植物属于自然保护联盟的稀有植物。在过去的几年中,由于跨界(尤其是来自中国)的巨大需求,P。polyphylla自然生长地区的当地人民了解其经济重要性。目前,该植物在中药系统(TCMS)中得到广泛使用,并且已经将该药草用作治疗癌症的传统药物。收集者之间不健康的竞争导致了对P. polyphylla的过度收获,而没有考虑其可持续再生。种子和根茎是该植物繁殖的媒介,如果在种子成熟之前收集该植物,那么这种有价值的植物的再生和生存无疑将在不久的将来受到威胁。因此,本文被重点介绍,并提出了保护后叶巴黎世代的紧迫需要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号